Member Info for Moneysponge

Who is Dr Tap ?

Sounds promising if he is some kind of oncology expert?

I guess who would want straight dox when ava6ooo is available that is similar priced? Significantly more safe and apparently more efficacious. Its the compassionate thing to do is replace straight dox and I presume marketing is straightforward as is manufacturing and time to market being an already existing drug.

Has all the Hallmarks this

Well clear of the 200 day moving average now on excellent volume

50, 100 & 200 DMA all starting to turn upwards

This really is looking exceptional

Bullish candles galore on multiple timeframes

People want this

Realistically, given the news this could rocket soon and never look back

Dangerous game to be trying to trade it for beer money

I learnt that the hard way after getting in sub £1 then slicing and then re-adding at £1.15ish

Any shorts will close

And if that RNS isn't enough for the long term holders who are under water to average down id be amazed

It will also attract newbies

This really is the perfect storm

MOre access to II's through PEEL

RNS's must have caught many attention

Huge volume on the chart will bring in traders

Alistair said they're seeing an uptick in commercial interest

Trial length shortened

Cash runway extended to beyond mid 2024

Lead candidate preCISION candidate smashing it out the park

Big pharmas sat on a M&A warchest

BDO taken on

CMO role filled

But yeah, Jadam sold at 1.19 and thinks AVCT need a deeply discounted placing

haha jog on lad.

AVCT is on a pathway to becoming a multi billion pound company and you're trading for beer money

Joker

Jadam sold at £1.19 believing this to be predictible and is gutted haha

poor bast

Why have a joint broker isnt that more costs?

Avacta had permission to go upto 400mg so why have they chosen 350 only?

Looks like the all time low will be tested here soon at 90p

Just what on earth is happening

Spread at less than 1%

Huge volume

200DMA smashed

RSI not even anywhere near overbought

Love it

Let's see this rip

It does not matter if it doesnt shrink more than with straight dox what matters is that it shrinks as much as straight dox and because of increased safety it becomes standard of care overnight

The bar is incredibly low and AVA6k is already way above itby reading between the lines

Take over is inevitible and the longer BP wait the more they will pay

Lol

You lot sat waiting for this totally overlooking avacta

theres a reason its valued at over 300m and climbing

Will outperform this by a country mile over the next 6 months

https://www.lse.co.uk/rns/AVCT/successful-completion-of-sixth-dose-escalation-zrrf1q03ftz4zoy.html

Here's your 50 bagger

If AVCT are shortly going to dose patients every 2 weeks with AVA6K as a first line treatment then when can we expect those results

I guess that will be included in the P1A dataset that is released by the end of the year

That will be the signal to big pharma to come get us

Whilst P2 is ongoing BIDS will come in you would expect as just a formality at that point

Not long now for a 30 - 100 bagger?

If they are running a paralel study between now and say christmas dosing every 2 weeks patients who are using this as a first line treatment then how extensive will P2 need to be? Surely this parallel study says all big pharma need to know?

Exactly Pedro

Boohoo will trade less then assets

not least because the assets are what primarily cheap clothes they couldnt shift and need to be written down

Shorts will have to close and when they do its like pooring fuel on a fire

Great RNS today

aleviates all concerns

Who gets a placing away at a 200% premium in this market??

HEMO thats who!

What I mean is that they need the MTD for AVA6k so when partners take it on and start using it say in conjunction with other chemos and to use it against other types of cancers it is incredibly useful to know what the MTD is.

I bet they already know the BED for AVA6K against STS

The next update i hope is full of information

I am looking forward to the investor event also

I can see myself becoming a long term investor here

Already actually regretting slicing what was a decent holding sub £1

They will need to know the MTD because not all cancers will respond the same

STS might only need say half the dose that breast cancer does for example

They need the MTD so then they can tailor all sorts of other trials going forward

the data is immensely valuable to us to patients and to big pharma

Just chill

its coming

All you need to actually do here is

NOTHING

Stock will hit 110, maybe 108 ish then bounce higher

Things always move in zig zags

Trying to catch the zigs and avoid the zags is what traders like me do

I sliced on a zag after getting in sub £1 and left the rest to run now as think i might hold this one long term

I wouldnt want to be fully out if and when that RNS lands put it that way

From what I am learning this does seem like not your usual AIM turd

Long term holders who sold at 200DMA for a bit of arbitrage now getting FOMO and buying back

lol

Chart looks good here

Can see this testing new ATH's in near future

Bodes well

small pullback expecting 110, maybe 108 min then this takes off again